Sanofi sues US FDA over OTC Nasacort

12 November 2013 - Deborah Wilkes

Archived

Sanofi has filed a lawsuit to prevent the US Food and Drug Administration (FDA) releasing details of the labelling and packaging for the OTC version of its Nasacort AQ (triamcinolone acetonide) nasal spray.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: